Omega Healthcare Investors (OHI)
(Delayed Data from NYSE)
$40.63 USD
+0.68 (1.70%)
Updated Oct 15, 2024 04:00 PM ET
After-Market: $40.63 0.00 (0.00%) 6:44 PM ET
4-Sell of 5 4
D Value D Growth C Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$40.63 USD
+0.68 (1.70%)
Updated Oct 15, 2024 04:00 PM ET
After-Market: $40.63 0.00 (0.00%) 6:44 PM ET
4-Sell of 5 4
D Value D Growth C Momentum D VGM
Zacks News
Omega Healthcare Investors (OHI) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Omega Healthcare Investors (OHI) closed at $28.36 in the latest trading session, marking a -0.6% move from the prior day.
Omega Healthcare Investors (OHI) Gains But Lags Market: What You Should Know
by Zacks Equity Research
In the latest trading session, Omega Healthcare Investors (OHI) closed at $28.47, marking a +0.46% move from the previous day.
Omega Healthcare Investors (OHI) Misses Q4 FFO and Revenue Estimates
by Zacks Equity Research
Omega Healthcare Investors (OHI) delivered FFO and revenue surprises of -6.10% and 7%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Omega Healthcare Investors (OHI) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Omega Healthcare Investors (OHI) closed at $30.31, marking a -0.26% move from the previous day.
Omega Healthcare Investors (OHI) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Omega Healthcare Investors (OHI) closed at $31.63, marking a +1.48% move from the previous day.
Omega Healthcare Investors (OHI) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Omega Healthcare Investors (OHI) closed the most recent trading day at $31.28, moving +0.48% from the previous trading session.
Omega Healthcare Investors (OHI) Stock Moves -0.1%: What You Should Know
by Zacks Equity Research
Omega Healthcare Investors (OHI) closed the most recent trading day at $30.40, moving -0.1% from the previous trading session.
Omega Healthcare Investors (OHI) Gains As Market Dips: What You Should Know
by Zacks Equity Research
In the latest trading session, Omega Healthcare Investors (OHI) closed at $30.43, marking a +1.16% move from the previous day.
Omega Healthcare Investors (OHI) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Omega Healthcare Investors (OHI) closed at $29.31, marking a +0.55% move from the previous day.
Omega Healthcare Investors (OHI) Gains But Lags Market: What You Should Know
by Zacks Equity Research
In the latest trading session, Omega Healthcare Investors (OHI) closed at $28.33, marking a +0.18% move from the previous day.
Omega Healthcare Investors (OHI) Stock Moves -0.68%: What You Should Know
by Zacks Equity Research
Omega Healthcare Investors (OHI) closed at $27.61 in the latest trading session, marking a -0.68% move from the prior day.
Omega Healthcare Investors (OHI) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Omega Healthcare Investors (OHI) closed the most recent trading day at $28.01, moving -1.27% from the previous trading session.
Omega Healthcare Investors (OHI) Beats Q3 FFO and Revenue Estimates
by Zacks Equity Research
Omega Healthcare Investors (OHI) delivered FFO and revenue surprises of 3.66% and 4.31%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
Omega Healthcare Investors (OHI) Q2 FFO Surpass Estimates
by Zacks Equity Research
Omega Healthcare Investors (OHI) delivered FFO and revenue surprises of 2.41% and -3.49%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Omega Healthcare Investors (OHI) Just Overtook the 50-Day Moving Average
by Zacks Equity Research
Is it a good or bad thing when a stock surpasses resistance at the 50-day simple moving average?
Omega Healthcare Investors (OHI) Q1 FFO and Revenues Top Estimates
by Zacks Equity Research
Omega Healthcare Investors (OHI) delivered FFO and revenue surprises of 3.66% and 4.44%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Is a Surprise Coming for Omega (OHI) This Earnings Season?
by Zacks Equity Research
Omega (OHI) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Omega Healthcare Investors (OHI) Q4 FFO Match Estimates
by Zacks Equity Research
Omega Healthcare Investors (OHI) delivered FFO and revenue surprises of 0.00% and 3.33%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
Four Corners on Buyout Spree, Acquires 2 Seritage Properties
by Zacks Equity Research
Four Corners' (FCPT) acquisitions are part of its efforts to capitalize on solid acquisition opportunities, backed by balance-sheet strength, and boost the company's portfolio growth.
Lamar (LAMR) to Raise 146.9M With Private Placement of Notes
by Zacks Equity Research
Lamar (LAMR) resorts to debt financing with a $150-million senior unsecured notes offering. The proceeds from the offering will be used to address near-term debt maturities.
Pebblebrook (PEB) Provides Operating Trend Update for Q3
by Zacks Equity Research
Continued hotel openings in the third quarter enable Pebblebrook (PEB) to reduce monthly hotel portfolio cash burn by $6 million from the May estimate.
Is it Wise to Hold On to PS Business Parks (PSB) Stock Now?
by Zacks Equity Research
PS Business Parks (PSB) will likely gain from its diversified portfolio, asset-repositioning moves and balance-sheet strength though a sluggish economy and rent-collection woes are concerns.
Lexington Realty Prices $400M of Senior Notes at 99.233%
by Zacks Equity Research
Lexington Realty (LXP) to boost liquidity and address near-term debt maturities with a senior unsecured notes offering.
LGI Homes (LGIH) Soars to 52-Week High, Time to Cash Out?
by Zacks Equity Research
LGI Homes (LGIH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Top Ranked Income Stocks to Buy for June 30th
by Zacks Equity Research
Here are three stocks with buy rank and strong income characteristics for investors to consider today, June 30th